EPISODE · Sep 20, 2023 · 22 MIN
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
from The LDN Radio Show About Low Dose Naltrexone
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
Embed this episode
NOW PLAYING
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
0:00
22:24
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The LDN Radio Show About Low Dose Naltrexone?
This episode is 22 minutes long.
When was this The LDN Radio Show About Low Dose Naltrexone episode published?
This episode was published on September 20, 2023.
Can I download this The LDN Radio Show About Low Dose Naltrexone episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!